65 related articles for article (PubMed ID: 12479845)
1. Action of topoisomerase targeting drugs on non-Hodgkin's lymphoma and leukemia. Correlation of clinical and cell culture studies.
Nair JS; Kancherla R; Seiter K; Traganos F; Tse-Dinh YC
Ann N Y Acad Sci; 2000; 922():326-9. PubMed ID: 11193914
[No Abstract] [Full Text] [Related]
2. Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agent.
Ellis AL; Nowak B; Plunkett W; Zwelling LA
Cancer Chemother Pharmacol; 1994; 34(3):249-56. PubMed ID: 8004759
[TBL] [Abstract][Full Text] [Related]
3. A phase I and pharmacodynamic study of sequential topotecan and etoposide in patients with relapsed or refractory acute myelogenous and lymphoblastic leukemia.
Cooper BW; Donaher E; Lazarus HM; Green SB; Gosky DM; Rosenthal NS; Berger SJ; Li X; Ingalls ST; Hoppel CL; Gerson SL
Leuk Res; 2003 Jan; 27(1):35-44. PubMed ID: 12479850
[TBL] [Abstract][Full Text] [Related]
4. Treatment of refractory acute leukemia with timed sequential chemotherapy using topotecan followed by etoposide + mitoxantrone (T-EM) and correlation with topoisomerase II levels.
Mainwaring MG; Rimsza LM; Chen SF; Gomez SP; Weeks FW; Reddy V; Lynch J; May WS; Kahn S; Moreb J; Leather H; Braylan R; Rowe TC; Fieniewicz KJ; Wingard JR
Leuk Lymphoma; 2002 May; 43(5):989-99. PubMed ID: 12148910
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of topotecan and etoposide for non-Hodgkin lymphoma: correlation of topoisomerase-DNA complex formation with clinical response.
Kancherla RR; Nair JS; Ahmed T; Durrani H; Seiter K; Mannancheril A; Tse-Dinh YC
Cancer; 2001 Feb; 91(3):463-71. PubMed ID: 11169927
[TBL] [Abstract][Full Text] [Related]
6. Commentary: topoisomerases as targets in acute leukemia: I, II, I plus II or none?
Malek SN; Gore SD
Leuk Res; 2003 Jan; 27(1):1-3. PubMed ID: 12479845
[No Abstract] [Full Text] [Related]
7. Topoisomerases in human leukemia.
Peereboom D; Charron M; Kaufmann SH
Adv Pharmacol; 1994; 29B():33-50. PubMed ID: 8996600
[No Abstract] [Full Text] [Related]
8. Induction of apoptosis by topotecan: implications for the treatment of leukemia.
Seiter K
Semin Hematol; 1998 Jul; 35(3 Suppl 4):22-5. PubMed ID: 9779878
[TBL] [Abstract][Full Text] [Related]
9. Topoisomerase enzymes as drug targets.
Guichard SM; Danks MK
Curr Opin Oncol; 1999 Nov; 11(6):482-9. PubMed ID: 10550012
[TBL] [Abstract][Full Text] [Related]
10. Topotecan - A novel topoisomerase I inhibitor: pharmacology and clinical experience.
Kollmannsberger C; Mross K; Jakob A; Kanz L; Bokemeyer C
Oncology; 1999; 56(1):1-12. PubMed ID: 9885371
[TBL] [Abstract][Full Text] [Related]
11. Topoisomerase II and the response to antileukemic therapy.
Kaufmann SH; Gore SD; Miller CB; Jones RJ; Zwelling LA; Schneider E; Burke PJ; Karp JE
Leuk Lymphoma; 1998 Apr; 29(3-4):217-37. PubMed ID: 9684921
[TBL] [Abstract][Full Text] [Related]
12. An overview of topoisomerase I-targeting agents.
Arbuck SG; Takimoto CH
Semin Hematol; 1998 Jul; 35(3 Suppl 4):3-12. PubMed ID: 9779876
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
